These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23792814)

  • 1. Bioinformatics methods for the analysis of hepatitis viruses.
    Moriconi F; Beard MR; Yuen LK
    Antivir Ther; 2013; 18(3 Pt B):531-9. PubMed ID: 23792814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome.
    Delaney WE
    Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of HBV/HCV coinfection.
    Potthoff A; Manns MP; Wedemeyer H
    Expert Opin Pharmacother; 2010 Apr; 11(6):919-28. PubMed ID: 20166841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiviral therapy in the management of hepatocellular carcinoma.
    Guan YS; He Q
    Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational chemistry perspective on the current status and future direction of hepatitis B antiviral drug discovery.
    Morgnanesi D; Heinrichs EJ; Mele AR; Wilkinson S; Zhou S; Kulp JL
    Antiviral Res; 2015 Nov; 123():204-15. PubMed ID: 26477294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical examinations based on nucleic acids of hepatitis viruses].
    Tanaka Y; Mizokami M
    Rinsho Byori; 2006 Nov; 54(11):1164-71. PubMed ID: 17240839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.
    Agrawal B; Kumar R
    World J Gastroenterol; 2016 Jul; 22(25):5623-6. PubMed ID: 27433078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
    Dervisevic S; Pillay D
    J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.